Denali Therapeutics Inc

Denali Therapeutics Inc. is a biotechnology company based in South San Francisco, California. The company employs 473 people and generated $82.9 million in revenue. Denali Therapeutics focuses on developing safe and effective medicines for patients suffering from neurodegenerative diseases. They achieve this through a scientific approach centered on three key principles: rigorous genetic target assessment, brain delivery engineering, and biomarker-guided development. The company emphasizes a work environment that is scientifically driven, impact-focused, supportive, and collaborative. Denali Therapeutics believes their ability to positively impact people's lives is directly linked to the trust within the team and their shared commitment to defeating neurodegenerative diseases. For more information, visit denalitherapeutics.com.